J Wilson

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation.

J Raftery, F Song, J. Raftery, 2005, Health technology assessment.

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.

P Barton, P. Barton, A. Burls, 2004, Health technology assessment.

A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.

J Raftery, J. Raftery, J. Bohlius, 2007, Health technology assessment.